Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 5
2004 3
2005 2
2006 10
2007 10
2008 6
2009 12
2010 12
2011 12
2012 7
2013 9
2014 9
2015 7
2016 8
2017 10
2018 16
2019 9
2020 6
2021 10
2022 5
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
Publisher Correction: Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs.
Petruk G, Puthia M, Samsudin F, Petrlova J, Olm F, Mittendorfer M, Hyllén S, Edström D, Strömdahl AC, Diehl C, Ekström S, Walse B, Kjellström S, Bond PJ, Lindstedt S, Schmidtchen A. Petruk G, et al. Among authors: schmidtchen a. Nat Commun. 2023 Oct 13;14(1):6436. doi: 10.1038/s41467-023-42294-3. Nat Commun. 2023. PMID: 37833291 Free PMC article. No abstract available.
Targeting Toll-like receptor-driven systemic inflammation by engineering an innate structural fold into drugs.
Petruk G, Puthia M, Samsudin F, Petrlova J, Olm F, Mittendorfer M, Hyllén S, Edström D, Strömdahl AC, Diehl C, Ekström S, Walse B, Kjellström S, Bond PJ, Lindstedt S, Schmidtchen A. Petruk G, et al. Among authors: schmidtchen a. Nat Commun. 2023 Sep 29;14(1):6097. doi: 10.1038/s41467-023-41702-y. Nat Commun. 2023. PMID: 37773180 Free PMC article.
Bioactive Suture with Added Innate Defense Functionality for the Reduction of Bacterial Infection and Inflammation.
Puthia M, Petrlova J, Petruk G, Butrym M, Samsudin F, Andersson MÅ, Strömdahl AC, Wasserstrom S, Hartman E, Kjellström S, Caselli L, Klementieva O, Bond PJ, Malmsten M, Raina DB, Schmidtchen A. Puthia M, et al. Among authors: schmidtchen a. Adv Healthc Mater. 2023 Dec;12(31):e2300987. doi: 10.1002/adhm.202300987. Epub 2023 Sep 21. Adv Healthc Mater. 2023. PMID: 37689972
Study protocol for a phase 1, randomised, double-blind, placebo-controlled study to investigate the safety, tolerability and pharmacokinetics of ascending topical doses of TCP-25 applied to epidermal suction blister wounds in healthy male and female volunteers.
Lundgren S, Wallblom K, Fisher J, Erdmann S, Schmidtchen A, Saleh K. Lundgren S, et al. Among authors: schmidtchen a. BMJ Open. 2023 Feb 22;13(2):e064866. doi: 10.1136/bmjopen-2022-064866. BMJ Open. 2023. PMID: 36813496 Free PMC article.
Editorial: Methods and applications in inflammation pharmacology.
Schmidtchen A, Mirza H, van der Plas MJA, Nadeem A, Puthia M. Schmidtchen A, et al. Front Pharmacol. 2022 Dec 12;13:1108263. doi: 10.3389/fphar.2022.1108263. eCollection 2022. Front Pharmacol. 2022. PMID: 36578538 Free PMC article. No abstract available.
155 results